S
Stockadora

Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 322 Events
🤖 AI Analyzed
Recent
📄 Page 25 of 27

PharmaCyte Biotech, Inc.

8-K December 5, 2025

Key Highlights

  • PharmaCyte Biotech received an official notice from Nasdaq for failing to meet t...
  • The company's common stock closed below $1.00 per share for 30 consecutive busin...
  • PharmaCyte has 180 calendar days, until June 1, 2026, to regain compliance by ha...
Read Analysis
🤖 AI Generated

OPGEN INC

8-K December 5, 2025

Key Highlights

  • OPGEN INC executed a reverse stock split to meet NASDAQ listing requirements and...
  • John Tan Honjian stepped down as CEO on December 1, 2025, but will continue as C...
  • Christian-Laurent Bonte was appointed as the new CEO on December 1, 2025, bringi...
Read Analysis
🤖 AI Generated

aTYR PHARMA INC

8-K December 5, 2025

Key Highlights

  • aTYR PHARMA INC received a deficiency notice from Nasdaq for failing to maintain...
  • The company's stock price closed below $1.00 for 30 consecutive business days, v...
  • This puts aTYR PHARMA at significant risk of being delisted from The Nasdaq Capi...
Read Analysis
🤖 AI Generated

PROS Holdings, Inc.

8-K December 5, 2025

Key Highlights

  • PROS Holdings stockholders overwhelmingly approved the company's acquisition and...
  • PROS will no longer be a publicly traded company, marking a massive change in it...
  • The decision was made at a special meeting of stockholders on December 4, 2025, ...
Read Analysis
🤖 AI Generated

OCULAR THERAPEUTIX, INC

8-K December 5, 2025

Key Highlights

  • OCULAR THERAPEUTIX, INC. filed an official report detailing its plans and signif...
  • AXPAXLI is a crucial product for treating wet age-related macular degeneration (...
  • The filing explicitly highlights major regulatory risks, including potential FDA...
Read Analysis
🤖 AI Generated

XWELL, Inc.

8-K December 5, 2025

Key Highlights

  • XWELL, Inc. received a warning letter from Nasdaq for failing to maintain a mini...
  • The company's stock price closed below $1.00 for 30 consecutive business days, f...
  • XWELL faces potential delisting from Nasdaq if it cannot regain compliance withi...
Read Analysis
🤖 AI Generated

Warner Bros. Discovery, Inc.

8-K December 5, 2025

Key Highlights

  • Netflix is acquiring Warner Bros.' entire film and television studios, including...
  • The massive deal is valued at approximately $82.7 billion (total) with an equity...
  • The acquisition is expected to close in Q3 2026, after WBD first separates its G...
Read Analysis
🤖 AI Generated

Carisma Therapeutics Inc.

8-K December 5, 2025

Key Highlights

  • Carisma Therapeutics Inc. is voluntarily delisting its stock from the Nasdaq exc...
  • The company plans to stop filing regular financial reports with the SEC.
  • Executive Natalie McAndrew resigned from her position.
Read Analysis
🤖 AI Generated

Ubiquiti Inc.

8-K December 5, 2025

Key Highlights

  • Ubiquiti board member Ronald A. Sege passed away unexpectedly on November 30, 20...
  • His passing caused Ubiquiti to fall out of compliance with NYSE rules regarding ...
  • Mr. Sege was posthumously re-elected as a Class II director at the Annual Meetin...
Read Analysis
🤖 AI Generated

CIMG Inc.

8-K December 5, 2025

Key Highlights

  • CIMG Inc. completed a 1-for-20 reverse stock split, exchanging 20 old shares for...
  • The split reduced the total number of outstanding shares from approximately 309....
  • The primary goal is to increase the stock price per share, aiming to meet Nasdaq...
Read Analysis
🤖 AI Generated

INTENSITY THERAPEUTICS, INC.

8-K December 5, 2025

Key Highlights

  • INTENSITY THERAPEUTICS, INC. received an extension from Nasdaq to regain complia...
  • The company's stock price has been trading below $1.00 per share, violating Nasd...
  • They now have until June 1, 2026, to get their stock price consistently above $1...
Read Analysis
🤖 AI Generated

PAVmed Inc.

8-K December 5, 2025

Key Highlights

  • PAVmed stockholders approved a reverse stock split and a significant reduction i...
  • The board of directors now has the power to implement a reverse stock split with...
  • The total authorized shares will be cut from 250,000,000 to 25,000,000.
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage